Table of Contents

Select this article
- B M Spiegelman
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Diabetes April 1998 47:507-514; doi:10.2337/diabetes.47.4.507
- Abstract
- Full Text (PDF)
Select this article
- L S Liu,
- M Spelleken,
- K Röhrig,
- H Hauner,
- and J Eckel
Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
Diabetes April 1998 47:515-522; doi:10.2337/diabetes.47.4.515
- Abstract
- Full Text (PDF)
Select this article
- D K Sindelar,
- C A Chu,
- P Venson,
- E P Donahue,
- D W Neal,
- and A D Cherrington
Basal hepatic glucose production is regulated by the portal vein insulin concentration.
Diabetes April 1998 47:523-529; doi:10.2337/diabetes.47.4.523
- Abstract
- Full Text (PDF)
Select this article
- M Tang-Christensen,
- N Vrang,
- and P J Larsen
Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
Diabetes April 1998 47:530-537; doi:10.2337/diabetes.47.4.530
- Abstract
- Full Text (PDF)
Select this article
- D G Baskin,
- R J Seeley,
- J L Kuijper,
- S Lok,
- D S Weigle,
- J C Erickson,
- R D Palmiter,
- and M W Schwartz
Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
Diabetes April 1998 47:538-543; doi:10.2337/diabetes.47.4.538
- Abstract
- Full Text (PDF)
Select this article
- M F Saad,
- A Khan,
- A Sharma,
- R Michael,
- M G Riad-Gabriel,
- R Boyadjian,
- S D Jinagouda,
- G M Steil,
- and V Kamdar
Physiological insulinemia acutely modulates plasma leptin.
Diabetes April 1998 47:544-549; doi:10.2337/diabetes.47.4.544
- Abstract
- Full Text (PDF)
Select this article
- K Kishi,
- N Muromoto,
- Y Nakaya,
- I Miyata,
- A Hagi,
- H Hayashi,
- and Y Ebina
Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
Diabetes April 1998 47:550-558; doi:10.2337/diabetes.47.4.550
- Abstract
- Full Text (PDF)
Select this article
- C Beger,
- V Cirulli,
- P Vajkoczy,
- P A Halban,
- and M D Menger
Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
Diabetes April 1998 47:559-565; doi:10.2337/diabetes.47.4.559
- Abstract
- Full Text (PDF)
Select this article
- T M Ellis,
- D A Schatz,
- E W Ottendorfer,
- M S Lan,
- C Wasserfall,
- P J Salisbury,
- J X She,
- A L Notkins,
- N K Maclaren,
- and M A Atkinson
The relationship between humoral and cellular immunity to IA-2 in IDDM.
Diabetes April 1998 47:566-569; doi:10.2337/diabetes.47.4.566
- Abstract
- Full Text (PDF)
Select this article
- L Liang,
- E Beshay,
- and G J Prud'homme
The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
Diabetes April 1998 47:570-575; doi:10.2337/diabetes.47.4.570
- Abstract
- Full Text (PDF)
Select this article
- H S Jun,
- Y Kang,
- H S Yoon,
- K H Kim,
- A L Notkins,
- and J W Yoon
Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
Diabetes April 1998 47:576-582; doi:10.2337/diabetes.47.4.576
- Abstract
- Full Text (PDF)
Select this article
- G Kwon,
- J A Corbett,
- S Hauser,
- J R Hill,
- J Turk,
- and M L McDaniel
Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
Diabetes April 1998 47:583-591; doi:10.2337/diabetes.47.4.583
- Abstract
- Full Text (PDF)
Select this article
- J Dittler,
- D Seidel,
- M Schenker,
- and A G Ziegler
GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Diabetes April 1998 47:592-597; doi:10.2337/diabetes.47.4.592
- Abstract
- Full Text (PDF)
Select this article
- T Hansen,
- S M Echwald,
- L Hansen,
- A M Møller,
- K Almind,
- J O Clausen,
- S A Urhammer,
- H Inoue,
- J Ferrer,
- J Bryan,
- L Aguilar-Bryan,
- M A Permutt,
- and O Pedersen
Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
Diabetes April 1998 47:598-605; doi:10.2337/diabetes.47.4.598
- Abstract
- Full Text (PDF)
Select this article
- E D Kilpatrick and
- R P Robertson
Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line.
Diabetes April 1998 47:606-611; doi:10.2337/diabetes.47.4.606
- Abstract
- Full Text (PDF)
Select this article
- G M Castillo,
- J A Cummings,
- W Yang,
- M E Judge,
- M J Sheardown,
- K Rimvall,
- J B Hansen,
- and A D Snow
Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Diabetes April 1998 47:612-620; doi:10.2337/diabetes.47.4.612
- Abstract
- Full Text (PDF)
Select this article
- K Tsuruzoe,
- E Araki,
- N Furukawa,
- T Shirotani,
- K Matsumoto,
- K Kaneko,
- H Motoshima,
- K Yoshizato,
- A Shirakami,
- H Kishikawa,
- J Miyazaki,
- and M Shichiri
Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
Diabetes April 1998 47:621-631; doi:10.2337/diabetes.47.4.621
- Abstract
- Full Text (PDF)
Select this article
- L A Scrocchi,
- B A Marshall,
- S M Cook,
- P L Brubaker,
- and D J Drucker
Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
Diabetes April 1998 47:632-639; doi:10.2337/diabetes.47.4.632
- Abstract
- Full Text (PDF)
Select this article
- S E Kahn,
- C B Verchere,
- S Andrikopoulos,
- P J Asberry,
- D L Leonetti,
- P W Wahl,
- E J Boyko,
- R S Schwartz,
- L Newell-Morris,
- and W Y Fujimoto
Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
Diabetes April 1998 47:640-645; doi:10.2337/diabetes.47.4.640
- Abstract
- Full Text (PDF)
Select this article
- D Flamez,
- A Van Breusegem,
- L A Scrocchi,
- E Quartier,
- D Pipeleers,
- D J Drucker,
- and F Schuit
Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
Diabetes April 1998 47:646-652; doi:10.2337/diabetes.47.4.646
- Abstract
- Full Text (PDF)
Select this article
- S Higashi,
- A C Clermont,
- V Dhir,
- and S E Bursell
Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
Diabetes April 1998 47:653-659; doi:10.2337/diabetes.47.4.653
- Abstract
- Full Text (PDF)
Select this article
- C Ferri,
- G Desideri,
- R Baldoncini,
- C Bellini,
- C De Angelis,
- C Mazzocchi,
- and A Santucci
Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
Diabetes April 1998 47:660-667; doi:10.2337/diabetes.47.4.660
- Abstract
- Full Text (PDF)
Select this article
- T Babazono,
- J Kapor-Drezgic,
- J A Dlugosz,
- and C Whiteside
Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
Diabetes April 1998 47:668-676; doi:10.2337/diabetes.47.4.668
- Abstract
- Full Text (PDF)
Select this article
- P Wentzel and
- U J Eriksson
Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro.
Diabetes April 1998 47:677-684; doi:10.2337/diabetes.47.4.677
- Abstract
- Full Text (PDF)
- G Argyropoulos,
- A M Brown,
- R Peterson,
- C E Likes,
- D K Watson,
- and W T Garvey
Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
Diabetes April 1998 47:685-687; doi:10.2337/diabetes.47.4.685
- Full Text (PDF)
- G A Hitman,
- N Mannan,
- M F McDermott,
- E Aganna,
- B W Ogunkolade,
- C N Hales,
- and B J Boucher
Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
Diabetes April 1998 47:688-690; doi:10.2337/diabetes.47.4.688
- Full Text (PDF)
Select this article
- S C Souza,
- M T Yamamoto,
- M D Franciosa,
- P Lien,
- and A S Greenberg
BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
Diabetes April 1998 47:691-695; doi:10.2337/diabetes.47.4.691
- Abstract
- Full Text (PDF)

Diabetes

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.

Basal hepatic glucose production is regulated by the portal vein insulin concentration.

Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.

Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.

Physiological insulinemia acutely modulates plasma leptin.

Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.

Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.

The relationship between humoral and cellular immunity to IA-2 in IDDM.

The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.

Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.

Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.

GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.

Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.

Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line.

Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.

Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.

Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.

Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.

Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.

Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.

Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.

Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.

Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro.

Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.

Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.

BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.

This Issue

Current Issue